Shionogi Of Japan Takes Hit As Resistant Strain Found To Flu Drug
This article was originally published in PharmAsia News
Executive Summary
Japan's Shionogi and its Rapiacta (peramivir) anti-flu drug that entered the market just over a year ago took a hit when health experts reported a new virus is resistant to it